Bone Biologics BBLGW
NASDAQ BBLGW
$8.24 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Bone Biologics Corp (BBLGW) Total Non-Current Liabilities (2022 - 2025)

Bone Biologics (BBLGW) posted quarterly Total Non-Current Liabilities of $417884.0 for Q4 2025, up 12.02% year-over-year from $373042.0 in Q4 2024, and up 25.46% quarter-over-quarter from $333081.0 in Q3 2025.

Bone Biologics Corp (BBLGW) Total Non-Current Liabilities (2022 - 2025) Analysis & Trends

Bone Biologics (BBLGW) has reported Total Non-Current Liabilities for 4 consecutive years, with $417884.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Total Non-Current Liabilities rose 12.02% year-over-year to $417884.0; the TTM figure through Dec 2025 stood at $417884.0 (up 12.02% YoY), while the FY2025 annual figure was $417884.0, up 12.02% from the prior year.
  • Total Non-Current Liabilities rose to $417884.0 in Q4 2025 per BBLGW's latest filing, from $333081.0 in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $2.3 million in Q1 2023 and bottomed at $146186.0 in Q1 2024.
  • Historically, Total Non-Current Liabilities has averaged $706885.5 across 4 years, with a median of $403729.0 in 2025.
  • Annual changes were most pronounced in 2024 — Total Non-Current Liabilities tumbled 93.59% — and 2025, when it jumped 69.54%.
  • Bone Biologics' Total Non-Current Liabilities stood at $888461.0 in 2022, then decreased by 12.7% to $775651.0 in 2023, then slumped by 51.91% to $373042.0 in 2024, then climbed by 12.02% to $417884.0 in 2025.
  • Business Quant data shows BBLGW's Total Non-Current Liabilities at $417884.0 in Q4 2025, $333081.0 in Q3 2025, and $403729.0 in Q2 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 417,884.00
Sep 30, 2025 333,081.00
Jun 30, 2025 403,729.00
Mar 31, 2025 247,843.00
Dec 31, 2024 373,042.00
Sep 30, 2024 255,773.00
Jun 30, 2024 276,852.00
Mar 31, 2024 146,186.00
Dec 31, 2023 775,651.00
Sep 30, 2023 1.10 Mn
Jun 30, 2023 1.69 Mn
Mar 31, 2023 2.28 Mn
Dec 31, 2022 888,461.00